Skip to content
Screener

Gross Profit at other companies

Amgen logo
AmgenAMGN
$7.24B+17.4%
Gilead Sciences logo
Gilead SciencesGILD
$6.22B+11.5%

Other financials

Income statement

See full
Revenue$238.9M+19,583%
Operating income$73.5M+162%
Net income$80.1M+172%
EPS (diluted)$0.47+159%

Balance sheet

See full
Cash & equivalents$287.6M-6.1%
Total debt$93.3M-8.8%
Total equity$982.5M+3.7%
Total assets$1.2B+1.9%

Cash flow

See full
Operating cash flow-$132.4M-69.5%
CapEx$32.0K-98.7%
Free cash flow-$132.8M-66.5%

Valuation

See full
Market cap$1.48B+111%
Enterprise value$1.29B+159%
P/S4.9×-32.1×

Profitability

See full
Gross margin96.1%-2.7pp
Operating margin-92.4%-45.5pp
Net margin-83%-40.9pp
FCF margin-686.5%-273pp

Returns & leverage

See full
Return on equity-26.1%-7.9pp
Debt / equity0.1×0.0×
Current ratio-1.0×

Where this comes from

Calculated from Vir Biotechnology, Inc.’s reported figures.

The source filing: Vir Biotechnology, Inc.’s 10-Q, filed August 5, 2026. Open the filing →

Filed
Aug 5, 2026, 5:20 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-053549

FAQ

What is Vir Biotechnology, Inc.'s gross profit?
Vir Biotechnology, Inc. (VIR) reported gross profit of $238.95M in Q2 2026.
How has Vir Biotechnology, Inc.'s gross profit changed year-over-year?
Vir Biotechnology, Inc.'s gross profit increased by 19762.5% year-over-year, from $1.2M to $238.95M.
What is the long-term trend for Vir Biotechnology, Inc.'s gross profit?
Over 3 years (2021 to 2024), Vir Biotechnology, Inc.'s gross profit has grown at a -58.5% compound annual growth rate (CAGR), from $1.03B to $73.36M.
What does gross profit mean?
Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.

Ask your AI about Vir Biotechnology, Inc.'s gross profit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude